The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results